The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...

(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

FDA has announced it has approved Torax Medical’s LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release. The LINX Reflux Management System is a ...

Johnson & Johnson (NYSE:JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, according to a Bloomberg report that ...

Mayo Clinic in Jacksonville, Fla., has announced it will be one of the first healthcare organizations in the United States to offer the LINX Reflux Management System to treat gastroesophageal reflux ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...